July 2026
1. YOON J, Shon K, Park HC, Lee S, et al
   Access Type-Specific Vascular Access Creation Timing in Incident Hemodialysis: A Nationwide Cohort Study.
   Am J Nephrol. 2026 Jul 14:1-25. doi: 10.1159/000553533.
   

   >> Share

   
   
2. OLIVEIRA BA, Barakat MF, Macdougall IC, Okonko DO, et al
   Prognostic Relevance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of Intravenous Iron Benefit in Maintenance Hemodialysis Patients.
   Am J Nephrol. 2026 Jul 13:1-17. doi: 10.1159/000552970.
   

   >> Share

   
   
3. ERIGUCHI M, Orihara S, Onishi Y, Matsui M, et al
   Context-Dependent Prognostic Significance of Total Iron-Binding Capacity by Nutritional and Inflammatory Status in Hemodialysis.
   Am J Nephrol. 2026 Jul 7:1-18. doi: 10.1159/000553442.
   

   >> Share

   
   
4. HE M, Erickson KF, Kassem H, Montez-Rath ME, et al
   Safety and Effectiveness of Apixaban Versus Warfarin in Peritoneal Dialysis Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation.
   Am J Nephrol. 2026 Jul 7:1-22. doi: 10.1159/000553428.
   

   >> Share

   
   
5. RAVI KS, Mc Causland FR
   Metabolic Syndrome and Risk of Atrial Fibrillation in Chronic Kidney Disease.
   Am J Nephrol. 2026 Jul 2:1-28. doi: 10.1159/000553385.
   

   >> Share

   
   June 2026
6. SHI L, Zheng K, Qian Y, Zheng X, et al
   Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.
   Am J Nephrol. 2026 Jun 25:1-23. doi: 10.1159/000553205.
   

   >> Share

   
   
7. O APOS LONE E, Mark PB
   Adjudicating heart failure as an end point in dialysis trials- more signal, less noise.
   Am J Nephrol. 2026 Jun 25:1-10. doi: 10.1159/000553102.
   

   >> Share

   
   
8. KANG G, Abdalla S, Parfrey PS, Lopes RD, et al
   Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
   Am J Nephrol. 2026 Jun 19:1-19. doi: 10.1159/000553103.
   

   >> Share

   
   
9. RANDHAY A, Selby NM, Taal MW, Eldehni MT, et al
   Associations of body composition biomarkers with survival, cardiovascular events and progression in persons with chronic kidney disease: insights from Renal Risk in Derby Study.
   Am J Nephrol. 2026 Jun 2:1-18. doi: 10.1159/000552844.
   

   >> Share

   
   May 2026
10. TANVEER FS, Saeed MH
    Forecasting Urgent Dialysis Needs: From Predictive Accuracy to Clinical Actionability.
    Am J Nephrol. 2026 May 8:1-2. doi: 10.1159/000551551.
    

    >> Share

    
    
11. BRITT-SPELLS AM, Buford J, Kelty C, Manjal P, et al
    Association Between Rurality and Evaluation Start Among Referred Patients with End Stage Kidney Disease.
    Am J Nephrol. 2026 May 6:1-17. doi: 10.1159/000552281.
    

    >> Share

    
    April 2026
12. ELENJICKAL EJ, Mavrakanas TA
    Mineralocorticoid Receptor Antagonists in Dialysis.
    Am J Nephrol. 2026 Apr 15:1-27. doi: 10.1159/000551881.
    

    >> Share

    
    March 2026
13. WU H, Ai Z, Liu A, Ye H, et al
    The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (recombinant human erythropoietin), Open-Label Study?the ENARODIAL stud
    Am J Nephrol. 2026 Mar 12:1-23. doi: 10.1159/000550548.
    

    >> Share

    
    
14. MA J, Yang X, Xiao X, Sun C, et al
    A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Desidustat's Efficacy and Safety in Non-Dialysis Chronic Kidney Disease Patients with Anemia.
    Am J Nephrol. 2026 Mar 5:1-24. doi: 10.1159/000551113.
    

    >> Share

    
    February 2026
15. BADVE SV, Al Ammari M, Anderson CS, Billot L, et al
    Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.
    Am J Nephrol. 2026 Feb 9:1-21. doi: 10.1159/000550796.
    

    >> Share

    
    
16. DAVIES MD, Briggs J, Alejmi A, Macdonald JH, et al
    Exercise Training And Progression Of Chronic Kidney Disease: The GFR-Exercise (GFR-Ex) Randomized Controlled Feasibility Study.
    Am J Nephrol. 2026 Feb 5:1-32. doi: 10.1159/000549971.
    

    >> Share

    
    January 2026
17. MCDONNELL T, Soderberg M, Taal MW, Vuilleumier N, et al
    Authors' Response to "Urinary and Plasma KIM-1 in Chronic Kidney Disease: Prognostic Insights and Remaining Questions".
    Am J Nephrol. 2026 Jan 23:1-2. doi: 10.1159/000550127.
    

    >> Share

    
    
18. WAN M, Yi C, Wang Y, Qiu Y, et al
    A comparative analysis of left ventricular myocardial work in patients with diabetic and non?diabetic kidney disease after peritoneal dialysis.
    Am J Nephrol. 2026 Jan 15:1-19. doi: 10.1159/000550324.
    

    >> Share

    
    
19. LI R, Hui M, Chen P, Zhang D, et al
    The Association of Proteinuria Target Achievement Timing and Stability with Adverse Kidney Outcomes among Patients with IgA Nephropathy: A Cohort Study.
    Am J Nephrol. 2026;57:409-425.
    

    >> Share

    
    December 2025
20. ZHENG S, Agarwal A
    Options for Hemodialysis Vascular Access- Should We Reconsider?
    Am J Nephrol. 2025 Dec 22:1-9. doi: 10.1159/000550131.
    

    >> Share

    
    
21. NAKAGAWA Y, Ito M, Tomita Y, Nakamura M, et al
    Elevated Glycerol-3-Phosphate in Patients Undergoing Hemodialysis: Associations with Phosphate and Fibroblast Growth Factor 23.
    Am J Nephrol. 2025 Dec 17:1-16. doi: 10.1159/000550130.
    

    >> Share

    
    
22. QING J, Cheungpasitporn W, Qin K, Wang X, et al
    The Power of Multiple Artificial Intelligence Models to Predict Global Chronic Kidney Disease Incidence: Who Leads the Race?
    Am J Nephrol. 2025 Dec 12:1-10. doi: 10.1159/000549005.
    

    >> Share

    
    
23. LIU Q, Liu T, Fang Z, He R, et al
    The Effect of Febuxostat on Kidney Outcomes in Patients with Chronic Kidney Disease and Asymptomatic Hyperuricemia: A Target Trial Emulation.
    Am J Nephrol. 2025 Dec 12:1-18. doi: 10.1159/000550047.
    

    >> Share

    
    
24. RAPOSO M, Akcay OF
    Urinary and Plasma KIM-1 in Chronic Kidney Disease: Prognostic Insights and Remaining Questions.
    Am J Nephrol. 2025 Dec 4:1-2. doi: 10.1159/000549046.
    

    >> Share

    
    November 2025
25. GAO F, Zhang J, Zhu H, Li W, et al
    Diffusion-weighted Imaging with T2 Mapping for Evaluation of Delayed Renal Function Recovery after Renal Transplantation.
    Am J Nephrol. 2025 Nov 28:1-16. doi: 10.1159/000549532.
    

    >> Share

    
    
26. LIM B, Zhu K, Zorcic K, Chan CTM, et al
    Building and prospectively evaluating a prediction model to forecast urgent dialysis needs across four tertiary hospitals.
    Am J Nephrol. 2025 Nov 24:1-11. doi: 10.1159/000549256.
    

    >> Share

    
    
27. OZIEH MN, Tung SH, Wang X, Thorgerson A, et al
    Trends and Independent Correlates of Chronic Kidney Disease Awareness in United States Adults: NHANES 1999-2020.
    Am J Nephrol. 2025 Nov 7:1-14. doi: 10.1159/000549324.
    

    >> Share

    
    October 2025
28. KOMABA H, Akari S, Ono Y, Fukagawa M, et al
    Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary Hyperparathyroidism: A Post-hoc Analysis of a Randomized Trial.
    Am J Nephrol. 2025 Oct 10:1-13. doi: 10.1159/000548738.
    

    >> Share

    
    September 2025
29. ZHAO S, Zhong G, Lv A, Tao Y, et al
    Intradialytic Exercise Interventions to Enhance Physical Activity Levels in Hemodialysis Patients: A Systematic Review and Meta-analysis.
    Am J Nephrol. 2025 Sep 26:1-35. doi: 10.1159/000548114.
    

    >> Share

    
    
30. JIN H, Lu R, Cao J, Li H, et al
    Inflammation-Driven Differential Response to Intravenous versus Oral Iron Supplementation in Hemodialysis Patients: A Post Hoc Analysis of the IHOPE Trial.
    Am J Nephrol. 2025 Sep 8:1-21. doi: 10.1159/000548166.
    

    >> Share

    
    August 2025
31. MCDONNELL T, Soderberg M, Taal MW, Vuilleumier N, et al
    Plasma and Urinary KIM-1 in Chronic Kidney Disease: Prognostic Value, Associations with Albuminuria, and Implications for Kidney Failure and Mortality.
    Am J Nephrol. 2025 Aug 11:1-20. doi: 10.1159/000547867.
    

    >> Share

    
    
32. FALLAHTAFTI P, Semirani-Nezhad D, Maleki S, Zafarmandi S, et al
    Intensive vs. Less Intensive Blood Pressure Control in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Clinical Trials.
    Am J Nephrol. 2025 Aug 6:1-18. doi: 10.1159/000547812.
    

    >> Share

    
    
33. ZOMORODIAN A, Sakhaee K
    Vitamin D in Chronic Kidney Disease: Familiar Treatment, Unresolved Questions.
    Am J Nephrol. 2025 Aug 4:1-5. doi: 10.1159/000547690.
    

    >> Share

    
    July 2025
34. KHAN LA, Alam B, Ladhwani NK, Abid H, et al
    Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: a systematic review and meta-analysis of short term randomized control trails.
    Am J Nephrol. 2025 Jul 9:1-20. doi: 10.1159/000546265.
    

    >> Share

    
    June 2025
35. VASAN SK, Chinnadurai R, Rengarajan S, Green D, et al
    Utility of cardiac biomarkers (NT-proBNP and Hs-Troponin-T) in predicting mortality, cardiovascular and renal outcomes in patients with chronic kidney disease.
    Am J Nephrol. 2025 Jun 24:1-21. doi: 10.1159/000546489.
    

    >> Share

    
    
36. ALGHWIRI AA, Weltman MR, Lavenburg LU, Han Z, et al
    Using Machine learning to predict medication therapy problems among patients with chronic kidney disease.
    Am J Nephrol. 2025 Jun 17:1-16. doi: 10.1159/000546540.
    

    >> Share

    
    
37. BISHOP CW, Ashfaq A, Choe J, Strugnell SA, et al
    Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Randomized Clinical Trial.
    Am J Nephrol. 2025 Jun 4:1-19. doi: 10.1159/000546615.
    

    >> Share

    
    May 2025
38. YOON SY, Jeong SJ, Kim JS, Hwang HS, et al
    Time in target range of systolic blood pressure and cardiovascular disease in patients with chronic kidney disease: A Korean nationwide cohort study.
    Am J Nephrol. 2025 May 19:1-21. doi: 10.1159/000546380.
    

    >> Share

    
    
39. GHILDAYAL N, Liu Y, Hong J, Li Y, et al
    Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, A Multi-Dialysis Center 2x2 Factorial Block-Randomized Controlled Trial.
    Am J Nephrol. 2025 May 10:1-23. doi: 10.1159/000546296.
    

    >> Share

    
    
40. WANG L, Cao Y, Yuan W, Hao C, et al
    Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-dependent CKD Patients.
    Am J Nephrol. 2025 May 6:1-25. doi: 10.1159/000546158.
    

    >> Share

    
    
41. KHAIRALLAH P, Liu S, Montez-Rath ME, Erickson KF, et al
    Association Between Parathyroid Hormone Concentration and Incident Atrial Fibrillation in Older Persons with Kidney Failure Initiating Dialysis.
    Am J Nephrol. 2025 May 5:1-18. doi: 10.1159/000546266.
    

    >> Share

    
    
42. KELTY CE, Buford J, Drewry KM, Adebiyi O, et al
    Sociodemographic barriers to starting the kidney transplantation evaluation process and waitlisting in the Ohio River Valley.
    Am J Nephrol. 2025 May 3:1-17. doi: 10.1159/000546108.
    

    >> Share

    
    April 2025
43. LEE CC, Chao JY, Liu KH, Lin WR, et al
    Longitudinal Changes in Peritoneal Transport and Their Impact on Dialysis Outcomes: A Machine Learning Approach integrating Clinical and Biomarker Data.
    Am J Nephrol. 2025 Apr 18:1-25. doi: 10.1159/000545943.
    

    >> Share

    
    March 2025
44. SONG S, Cai X, Shen D, Hu J, et al
    Relationship between cumulative exposure and time course of plasma aldosterone concentrations and chronic kidney disease in hypertensive patients: a real-world cohort study.
    Am J Nephrol. 2025 Mar 29:1-22. doi: 10.1159/000545451.
    

    >> Share

    
    
45. LI D, Xie D, Gu A, Yang Y, et al
    Pharmacokinetic Properties of Dapagliflozin in Patients with Stage 4 Chronic Kidney Disease.
    Am J Nephrol. 2025 Mar 14:1-16. doi: 10.1159/000544936.
    

    >> Share

    
    
46. OKAMURA K, Tanaka S, Kitamura H, Suenaga T, et al
    Associations Between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2025 Mar 13:1-25. doi: 10.1159/000544722.
    

    >> Share

    
    
47. CHANDER S, Latif R, Bin Aamir A, Sorath F, et al
    Clinical outcomes of patients undergoing hemodialysis with cool versus standard dialysate: A systematic review and meta-analysis.
    Am J Nephrol. 2025 Mar 3:1-28. doi: 10.1159/000544924.
    

    >> Share

    
    February 2025
48. LIM W, Gately R, Teixeira-Pinto A, Lopez P, et al
    Sex disparity and the uptake of home dialysis following kidney transplant failure.
    Am J Nephrol. 2025 Feb 26:1-19. doi: 10.1159/000543788.
    

    >> Share

    
    
49. WESTERMANN L, Nolde JM, Wiegel J, Buchler G, et al
    Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression - a Retrospective Observational Study.
    Am J Nephrol. 2025 Feb 26:1-15. doi: 10.1159/000543487.
    

    >> Share

    
    
50. JI J, Lu M, Guo S, Xiang B, et al
    Five-year Time Profiles of Clearances of Different Uremic Solutes in Incident Peritoneal Dialysis Patients.
    Am J Nephrol. 2025 Feb 25:1-17. doi: 10.1159/000543622.
    

    >> Share

    
    
51. ASHFAQ A, Choe J, Strugnell SA, Patel N, et al
    Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (ERC) in non-dialysis chronic kidney disease (ND-CKD).
    Am J Nephrol. 2025 Feb 21:1-21. doi: 10.1159/000544086.
    

    >> Share

    
    
52. HAMANO N, Komaba H, Tanaka H, Takahashi H, et al
    Fibroblast Growth Factor 23, Endogenous Erythropoietin, Erythropoiesis-Stimulating Agents, and Erythropoietin Resistance in Hemodialysis Patients.
    Am J Nephrol. 2025 Feb 20:1-9. doi: 10.1159/000543506.
    

    >> Share

    
    
53. MERZKANI M, Attieh RM, Jhaveri KD, Murakami N, et al
    Immunotherapy and cellular therapies for cancers in kidney transplant patients.
    Am J Nephrol. 2025 Feb 20:1-23. doi: 10.1159/000544826.
    

    >> Share

    
    
54. YAO C, Wei W, Wu G, Zhang Y, et al
    DOT1L regulates cellular senescence during the progression from acute kidney injury to chronic kidney disease via the micro-222-5p/WNT9B signaling pathway.
    Am J Nephrol. 2025 Feb 12:1-20. doi: 10.1159/000544694.
    

    >> Share

    
    
55. POULAIN L, Bechade C, Lanot A, Ficheux M, et al
    Early-onset peritonitis and outcomes of peritoneal dialysis: A cohort study with data from the RDPLF.
    Am J Nephrol. 2025 Feb 3:1-23. doi: 10.1159/000542835.
    

    >> Share

    
    January 2025
56. NISHIWAKI H, Imaizumi T, Hasegawa T, Kosugi T, et al
    Association between serum iron store biomarkers and all-cause mortality in Japanese patients undergoing hemodialysis: a nationwide cohort study.
    Am J Nephrol. 2025 Jan 31:1-23. doi: 10.1159/000543888.
    

    >> Share

    
    
57. HORI M, Takahashi H, Kondo C, Takeda A, et al
    Association between serum zinc levels and trabecular bone scores among patients undergoing chronic hemodialysis.
    Am J Nephrol. 2025 Jan 24:1-13. doi: 10.1159/000543756.
    

    >> Share

    
    
58. LIN YT, Tsai MT, Chen TW, Lin CC, et al
    Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis.
    Am J Nephrol. 2025 Jan 22:1-19. doi: 10.1159/000543598.
    

    >> Share

    
    
59. PHONGPHITHAKCHAI A, Bellomo R, Mount P, Bach CT, et al
    A pilot, single-blinded, randomized cross-over trial of cramp reduction with angiotensin II in maintenance patients on hemodialysis (The CRAMP-HD study).
    Am J Nephrol. 2025 Jan 14:1-19. doi: 10.1159/000543280.
    

    >> Share

    
    
60. KITAMURA H, Tanaka S, Hiyamuta H, Tsuruya K, et al
    Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney disease Registry (FKR) Study.
    Am J Nephrol. 2025 Jan 8:1-21. doi: 10.1159/000543201.
    

    >> Share

    
    
61. YU H, Kim SJ, Bae Y, Kim M, et al
    Sex differences in the risk of bladder cancer among kidney transplant recipients and patients with kidney failure receiving hemodialysis: a nationwide cohort study.
    Am J Nephrol. 2025 Jan 7:1-16. doi: 10.1159/000543298.
    

    >> Share

    
    
62. KOH J, Yang J, Lee KB, Kim J, et al
    Performance of new race-free eGFR equations for predicting complications in chronic kidney disease: From the KNOW-CKD study.
    Am J Nephrol. 2025 Jan 2:1-17. doi: 10.1159/000543324.
    

    >> Share

    
    
63. CHADE AR, Tharp DL, Sitz R, McCarthy EA, et al
    A NEW MODEL OF CHRONIC KIDNEY DISEASE, METABOLIC DERANGEMENTS, AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN AGING SWINE.
    Am J Nephrol. 2025 Jan 2:1-20. doi: 10.1159/000543327.
    

    >> Share

    
    
64. FENG L, Song X, Shi X, Qin M, et al
    Off-Label Use of Mycophenolate Mofetil in Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2025;56:35-47.
    

    >> Share

    
    
65. JEON J, Shin DW, Park SH, Jung JH, et al
    Kidney and Cardiovascular Outcomes in Older Population with Mildly to Moderately Decreased Kidney Function: A Nationwide Cohort Study.
    Am J Nephrol. 2025;56:123-135.
    

    >> Share

    
    
66. TAKAHASHI R, Bui TA, Elali I, Tran D, et al
    The Association of Niacin Use with Kidney Outcomes and Mortality.
    Am J Nephrol. 2025;56:457-467.
    

    >> Share

    
    
67. MCDONALD S, Stallard BC, McDonald SP
    Gender Differences in Kidney Failure Incidence in Australia: A Registry Study.
    Am J Nephrol. 2025;56:571-576.
    

    >> Share

    
    December 2024
68. LI W, Cao T, Huang G, Guo J, et al
    Effects of roxadustat on thyroid profiles in patients and animals with chronic kidney disease.
    Am J Nephrol. 2024 Dec 9:1-23. doi: 10.1159/000542699.
    

    >> Share

    
    November 2024
69. KIM I, Min SH, Lee HW, An JN, et al
    Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis.
    Am J Nephrol. 2024 Nov 7:1-17. doi: 10.1159/000542427.
    

    >> Share

    
    
70. FERREIRA JP, Oliveira AC, Vasques-Novoa F, Leite AR, et al
    Mineralocorticoid receptor antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor alone in chronic kidney disease: a meta-analysis of randomized trials.
    Am J Nephrol. 2024 Nov 7:1-13. doi: 10.1159/000541686.
    

    >> Share

    
    
71. ZOCCALI C, Mallamaci F
    The Interplay of Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Call for Integrated Management.
    Am J Nephrol. 2024 Nov 5:1-4. doi: 10.1159/000541889.
    

    >> Share

    
    October 2024
72. SHIAO CC, Chiu CW, Chang YM, Liu MC, et al
    Comprehensive Evaluation of the Cardiovascular Protective Effects of SGLT2 Inhibitors in Patients with Advanced Chronic Kidney Disease: A Real-World Evidence.
    Am J Nephrol. 2024 Oct 21:1-28. doi: 10.1159/000542132.
    

    >> Share

    
    
73. CHUANG GT, Hsiung CN, Che TP, Chang YC, et al
    Discovering Novel Loci of Chronic Kidney Disease via Principal Component Analysis based Multiple-trait Genome?wide Association Study.
    Am J Nephrol. 2024 Oct 21:1-25. doi: 10.1159/000541982.
    

    >> Share

    
    
74. PARK CH, Lim H, Kim YN, Kim JY, et al
    Non-alcoholic Fatty Liver Disease (NAFLD) and its association with kidney and cardiovascular outcomes in moderate to advanced chronic kidney disease.
    Am J Nephrol. 2024 Oct 4:1-23. doi: 10.1159/000541803.
    

    >> Share

    
    September 2024
75. LUO W, Lei L, Lai J, Liu Y, et al
    A risk prediction model for new-onset chronic kidney disease in the elderly.
    Am J Nephrol. 2024 Sep 23:1-26. doi: 10.1159/000541510.
    

    >> Share

    
    
76. HAMANO T, Koiwa F, Isaka Y, Yokoyama K, et al
    Long-term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-label 52-week Study.
    Am J Nephrol. 2024 Sep 19:1-23. doi: 10.1159/000541493.
    

    >> Share

    
    
77. MURAKAMI M, Fujii N, Kanda E, Kikuchi K, et al
    Association between timing of vascular access creation and mortality in patients initiating hemodialysis: A nationwide cohort study in Japan.
    Am J Nephrol. 2024 Sep 7. doi: 10.1159/000541356.
    

    >> Share

    
    August 2024
78. VANEK L, Gulmez D, Kurnikowski A, Krenn S, et al
    Patient and caregiver perspectives on gender disparity in chronic kidney disease: Questionnaire survey, based on an interview study.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000540850.
    

    >> Share

    
    
79. BISHOP CW, Ashfaq A, Strugnell SA, Choe J, et al
    Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000541138.
    

    >> Share

    
    
80. POLLOCK C, Carrero JJ, Kanda E, Ofori-Asenso R, et al
    The Lived Experience of Patients With Chronic Kidney Disease: Insights From DISCOVER CKD.
    Am J Nephrol. 2024 Aug 22. doi: 10.1159/000541064.
    

    >> Share

    
    
81. WEIR MR, Rossignol P, Pitt B, Lund LH, et al
    Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
    Am J Nephrol. 2024 Aug 19. doi: 10.1159/000540453.
    

    >> Share

    
    
82. KIM IS, Lee HS, Jang J, An JN, et al
    Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis Patients.
    Am J Nephrol. 2024 Aug 17. doi: 10.1159/000540948.
    

    >> Share

    
    July 2024
83. BLOCK GA, Mizani MR, Broumand V, Newby FD, et al
    A Randomized Trial of the IMPACT of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
    Am J Nephrol. 2024 Jul 5. doi: 10.1159/000540227.
    

    >> Share

    
    June 2024
84. ZIEGLER J, Morley K, Pilcher D, Bellomo R, et al
    Epidemiology of renal replacement therapy for critically ill patients across seven health jurisdictions.
    Am J Nephrol. 2024 Jun 18. doi: 10.1159/000539811.
    

    >> Share

    
    May 2024
85. SHAH AD, Vashisth S, Raker CA, Hu SL, et al
    Trends, Outcomes, and Economic Implications of Peritoneal Dialysis-Associated Peritonitis: A National Cohort Study.
    Am J Nephrol. 2024 May 30. doi: 10.1159/000539452.
    

    >> Share

    
    
86. MOLONEY BM, Chertow GM, Mc Causland FR
    Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
    Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
    

    >> Share

    
    
87. GARDEZI AI, Yuan Z, Aziz F, Parajuli S, et al
    Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure.
    Am J Nephrol. 2024 May 16. doi: 10.1159/000539062.
    

    >> Share

    
    
88. VAN REETH O, Caliment A, de la Fuente Garcia I, Niel O, et al
    Safety profile and effectiveness of dapagliflozin in pediatric patients with chronic kidney disease.
    Am J Nephrol. 2024 May 11. doi: 10.1159/000539300.
    

    >> Share

    
    
89. GENDY N, Brown L, Staunton MK, Garg K, et al
    The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients- An Ancillary Study From the FAVORIT.
    Am J Nephrol. 2024 May 10. doi: 10.1159/000538878.
    

    >> Share

    
    April 2024
90. ALSULAMI MM, Al-Otaibi NE, Alshahrani WA, Altheaby A, et al
    The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study.
    Am J Nephrol. 2024 Apr 26. doi: 10.1159/000538963.
    

    >> Share

    
    March 2024
91. LE D, Crews DC, Grams ME, Coresh J, et al
    Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis.
    Am J Nephrol. 2024 Mar 29. doi: 10.1159/000538253.
    

    >> Share

    
    
92. BOBOT M, Hak JF, Casolla B, Dehondt JD, et al
    Acute and chronic kidney dysfunction and prognosis following thrombectomy for ischemic stroke.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000536493.
    

    >> Share

    
    
93. TSAI YL, Chung MH, Lin NC, Chen CY, et al
    The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000538231.
    

    >> Share

    
    February 2024
94. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
    Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
    Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
    

    >> Share

    
    
95. MAKAWI AT, Tawfik YMK, Dixon DL, McMahon GM, et al
    Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.
    Am J Nephrol. 2024 Feb 28:1-4. doi: 10.1159/000536540.
    

    >> Share

    
    January 2024
96. HORI M, Takahashi H, Kondo C, Hayashi F, et al
    Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis.
    Am J Nephrol. 2024;55:399-405.
    

    >> Share

    
    
97. WANG Z, Zhou X, Shi S, Liu L, et al
    Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study.
    Am J Nephrol. 2024;55:529-538.
    

    >> Share

    
    
98. HOLDEN RM, Norman PA, Day AG, Silver SA, et al
    Vitamin D Status and Treatment in ESKD: Links to Improved CKD-MBD Laboratory Parameters in a Real-World Setting.
    Am J Nephrol. 2024;55:638-646.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share